公开(公告)号：US20240165179A1

公开(公告)日：2024-05-23

申请号：US18516756

申请日：2023-11-21

申请人： M2 Ingredients, Inc.

发明人： Samuel Andrasko ,  Julie Daoust ,  Steven Lee Farrar

IPC分类号： A61K36/068

CPC分类号： A61K36/068 ,  A61K2236/11 ,  A61K2236/15 ,  A61K2236/17

摘要： Exemplary embodiments include a whole mycelium of Cordyceps militaris designated as strain M2-105-04 as deposited with the ATCC Patent Depository under the Budapest Treaty (10801 University Blvd, Manassas, VA 20110), on Jul. 28, 2023, with the unofficial ATCC Patent Deposit Designation No. PTA-127612 and the official deposit date of Jul. 28, 2023 and the official patent deposit number of PTA-127612. The whole mycelium is characterized by a phenotype having an abundance of fruiting bodies on top of a substrate and/or along a parameter of a bioreactor bag. It is also characterized by a phenotype having fruiting initiation at or near 18 days after inoculation, a phenotype having fruiting bodies maturing at or near 55 days after inoculation, and/or a phenotype having a 10-to-15-day colonization time on hulled oats.

公开(公告)号：US20240164424A1

公开(公告)日：2024-05-23

申请号：US18514846

申请日：2023-11-20

申请人： M2 Ingredients, Inc.

发明人： Samuel Andrasko ,  Julie Daoust ,  Steven Lee Farrar

IPC分类号： A23L31/00 ,  A23L2/38 ,  A23P10/22 ,  C12N1/14

CPC分类号： A23L31/00 ,  A23L2/38 ,  A23P10/22 ,  C12N1/145

摘要： Embodiments of the present disclosure include Hericium erinaceus fungus designated as strain M2-102-10 as deposited with the ATCC Patent Depository under the Budapest Treaty (10801 University Blvd, Manassas, VA 20110), on Nov. 7, 2023, with the unofficial ATCC Patent Deposit Designation No. PTA-127680 and the official deposit date of ______ and the official Patent Deposit Designation No. ______. In some embodiments, the improved Hericium erinaceus fungus designated as strain M2-102-10 is characterized by having optimized concentrations of bioactive compounds. In some embodiments, a Beta-glucan concentration is 20 percent or greater.

公开(公告)号：US20240349663A1

公开(公告)日：2024-10-24

申请号：US18641246

申请日：2024-04-19

申请人： M2 Ingredients, Inc.

发明人： Samuel Andrasko ,  Julie Daoust ,  Steven Lee Farrar

IPC分类号： A01G18/40 ,  C12N1/14

CPC分类号： A01G18/40 ,  C12N1/14

摘要： Exemplary embodiments include Ganoderma lucidum fungus designated as strains M2-100-02 and M2-102-02 as deposited with the ATCC Patent Depository under the Budapest Treaty (10801 University Blvd, Manassas, VA 20110), on Jul. 28, 2023, with the unofficial ATCC Patent Deposit Designation No. PTA-127609 (strain M2-100-02) and the unofficial ATCC Patent Deposit Designation No. PTA-127610 (strain M2-102-02), and the official deposit date of Jul. 28, 2023 and the official Patent Deposit Designation No PTA-127609 (strain M2-100-02) and the official Patent Deposit Designation No. PTA-127610 (strain M2-102-02). In some embodiments, the improved Ganoderma lucidum fungus designated as strains M2-100-02 and M2-102-02 are characterized by having optimized concentrations of bioactive compounds including Ganoderic acids and triterpines. In some embodiments, a Beta-glucan concentration is 20 percent or greater. In some embodiments, Ganoderma lucidum fungus designated as strains M2-100-02 and M2-102-02 are improved to be grown on hydrated hulled oats.